AIM ImmunoTech, Inc. (AIM)
0.8107
-0.03
(-3.91%)
USD |
NYAM |
Feb 12, 16:00
0.8107
0.00 (0.00%)
After-Hours: 19:32
AIM ImmunoTech Total Liabilities (Quarterly) : 11.57M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 1.717B |
| Agenus, Inc. | 514.76M |
| Curis, Inc. | 42.33M |
| LadRx Corp. | 2.395M |
| Plus Therapeutics, Inc. | 13.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.494M |
| Shareholders Equity (Quarterly) | -6.077M |
| Debt to Equity Ratio | -0.3847 |
| Current Ratio | 0.6369 |
| Net Debt Paydown Yield | 2.70% |